BeiGene’s aggressive expansion brings revenue jolt
The innovative drug maker’s product revenue rose 82% to $747 million in the first quarter, with its star drug on pace to possibly net $2 billion for the year Key…
Recent Articles
BeiGene’s aggressive expansion brings revenue jolt
BGNE.US
6160.HK
688235.SHG
